Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William D Freeman

Showing results (191-200 of 193) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 193 results.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2018
Reducing Door-to-Reperfusion Time for Mechanical Thrombectomy With a Multitiered Notification System for Acute Ischemic StrokeEric D Goldstein, Lynda Schnusenberg, Lesia Mooney, et al.
Brain : a Journal of Neurology|June 17, 2024
De novo and inherited monoallelic variants in TUBA4A cause ataxia and spasticityMehdi Benkirane, Marion Bonhomme, Heba Morsy, et al.
Science Translational Medicine|October 22, 2020
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West, et al.
Pageof 20

Showing results (191-200 of 193) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 193 results.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2018
Reducing Door-to-Reperfusion Time for Mechanical Thrombectomy With a Multitiered Notification System for Acute Ischemic StrokeEric D Goldstein, Lynda Schnusenberg, Lesia Mooney, et al.
Brain : a Journal of Neurology|June 17, 2024
De novo and inherited monoallelic variants in TUBA4A cause ataxia and spasticityMehdi Benkirane, Marion Bonhomme, Heba Morsy, et al.
Science Translational Medicine|October 22, 2020
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West, et al.
Pageof 20